<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32570926</PMID><DateCompleted><Year>2021</Year><Month>03</Month><Day>01</Day></DateCompleted><DateRevised><Year>2021</Year><Month>03</Month><Day>01</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2072-6643</ISSN><JournalIssue CitedMedium="Internet"><Volume>12</Volume><Issue>6</Issue><PubDate><Year>2020</Year><Month>Jun</Month><Day>18</Day></PubDate></JournalIssue><Title>Nutrients</Title><ISOAbbreviation>Nutrients</ISOAbbreviation></Journal><ArticleTitle>Protocatechuic Acid Extends Survival, Improves Motor Function, Diminishes Gliosis, and Sustains Neuromuscular Junctions in the hSOD1<sup>G93A</sup> Mouse Model of Amyotrophic Lateral Sclerosis.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">1824</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/nu12061824</ELocationID><Abstract><AbstractText>Amyotrophic lateral sclerosis (ALS) is a devastating disorder characterized by motor neuron apoptosis and subsequent skeletal muscle atrophy caused by oxidative and nitrosative stress, mitochondrial dysfunction, and neuroinflammation. Anthocyanins are polyphenolic compounds found in berries that possess neuroprotective and anti-inflammatory properties. Protocatechuic acid (PCA) is a phenolic acid metabolite of the parent anthocyanin, kuromanin, found in blackberries and bilberries. We explored the therapeutic effects of PCA in a transgenic mouse model of ALS that expresses mutant human Cu, Zn-superoxide dismutase 1 with a glycine to alanine substitution at position 93. These mice display skeletal muscle atrophy, hindlimb weakness, and weight loss. Disease onset occurs at approximately 90 days old and end stage is reached at approximately 120 days old. Daily treatment with PCA (100 mg/kg) by oral gavage beginning at disease onset significantly extended survival (121 days old in untreated vs. 133 days old in PCA-treated) and preserved skeletal muscle strength and endurance as assessed by grip strength testing and rotarod performance. Furthermore, PCA reduced astrogliosis and microgliosis in spinal cord, protected spinal motor neurons from apoptosis, and maintained neuromuscular junction integrity in transgenic mice. PCA lengthens survival, lessens the severity of pathological symptoms, and slows disease progression in this mouse model of ALS. Given its significant preclinical therapeutic effects, PCA should be further investigated as a treatment option for patients with ALS.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Koza</LastName><ForeName>Lilia A</ForeName><Initials>LA</Initials><AffiliationInfo><Affiliation>Department of Biological Sciences, F. W. Olin Hall, Room 102, University of Denver, 2190 E. Iliff Ave, Denver, CO 80208, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Knoebel Institute for Healthy Aging, Engineering Computer Science, Suite 579, University of Denver, 2155 E. Wesley Ave, Denver, CO 80208, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Winter</LastName><ForeName>Aimee N</ForeName><Initials>AN</Initials><AffiliationInfo><Affiliation>Department of Biological Sciences, F. W. Olin Hall, Room 102, University of Denver, 2190 E. Iliff Ave, Denver, CO 80208, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Holsopple</LastName><ForeName>Jessica</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Biological Sciences, F. W. Olin Hall, Room 102, University of Denver, 2190 E. Iliff Ave, Denver, CO 80208, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Baybayon-Grandgeorge</LastName><ForeName>Angela N</ForeName><Initials>AN</Initials><AffiliationInfo><Affiliation>Department of Biological Sciences, F. W. Olin Hall, Room 102, University of Denver, 2190 E. Iliff Ave, Denver, CO 80208, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pena</LastName><ForeName>Claudia</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Biological Sciences, F. W. Olin Hall, Room 102, University of Denver, 2190 E. Iliff Ave, Denver, CO 80208, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Knoebel Institute for Healthy Aging, Engineering Computer Science, Suite 579, University of Denver, 2155 E. Wesley Ave, Denver, CO 80208, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Olson</LastName><ForeName>Jeffrey R</ForeName><Initials>JR</Initials><AffiliationInfo><Affiliation>Department of Biological Sciences, F. W. Olin Hall, Room 102, University of Denver, 2190 E. Iliff Ave, Denver, CO 80208, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Knoebel Institute for Healthy Aging, Engineering Computer Science, Suite 579, University of Denver, 2155 E. Wesley Ave, Denver, CO 80208, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mazzarino</LastName><ForeName>Randall C</ForeName><Initials>RC</Initials><AffiliationInfo><Affiliation>Department of Biological Sciences, F. W. Olin Hall, Room 102, University of Denver, 2190 E. Iliff Ave, Denver, CO 80208, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Knoebel Institute for Healthy Aging, Engineering Computer Science, Suite 579, University of Denver, 2155 E. Wesley Ave, Denver, CO 80208, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Patterson</LastName><ForeName>David</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Department of Biological Sciences, F. W. Olin Hall, Room 102, University of Denver, 2190 E. Iliff Ave, Denver, CO 80208, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Knoebel Institute for Healthy Aging, Engineering Computer Science, Suite 579, University of Denver, 2155 E. Wesley Ave, Denver, CO 80208, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Eleanor Roosevelt Institute, University of Denver, 2101 E. Wesley Ave, Denver, CO 80210, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Linseman</LastName><ForeName>Daniel A</ForeName><Initials>DA</Initials><AffiliationInfo><Affiliation>Department of Biological Sciences, F. W. Olin Hall, Room 102, University of Denver, 2190 E. Iliff Ave, Denver, CO 80208, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Knoebel Institute for Healthy Aging, Engineering Computer Science, Suite 579, University of Denver, 2155 E. Wesley Ave, Denver, CO 80208, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Eleanor Roosevelt Institute, University of Denver, 2101 E. Wesley Ave, Denver, CO 80210, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>PCA-ALS</GrantID><Agency>Ralph L. Smith Foundation</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>06</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Nutrients</MedlineTA><NlmUniqueID>101521595</NlmUniqueID><ISSNLinking>2072-6643</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016588">Anticarcinogenic Agents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D062385">Hydroxybenzoates</NameOfSubstance></Chemical><Chemical><RegistryNumber>36R5QJ8L4B</RegistryNumber><NameOfSubstance UI="C009091">protocatechuic acid</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 1.15.1.1</RegistryNumber><NameOfSubstance UI="D000072105">Superoxide Dismutase-1</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016588" MajorTopicYN="N">Anticarcinogenic Agents</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005911" MajorTopicYN="N">Gliosis</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000517" MajorTopicYN="Y">prevention &amp; control</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D062385" MajorTopicYN="N">Hydroxybenzoates</DescriptorName><QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008822" MajorTopicYN="N">Mice, Transgenic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009043" MajorTopicYN="N">Motor Activity</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009046" MajorTopicYN="N">Motor Neurons</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009469" MajorTopicYN="N">Neuromuscular Junction</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000072105" MajorTopicYN="N">Superoxide Dismutase-1</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015996" MajorTopicYN="N">Survival Rate</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">amyotrophic lateral sclerosis</Keyword><Keyword MajorTopicYN="N">anti-inflammatory</Keyword><Keyword MajorTopicYN="N">antioxidant</Keyword><Keyword MajorTopicYN="N">neurodegeneration</Keyword><Keyword MajorTopicYN="N">neuroprotective</Keyword><Keyword MajorTopicYN="N">phenolic acid</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>5</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>6</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>6</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>6</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>6</Month><Day>24</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>3</Month><Day>2</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32570926</ArticleId><ArticleId IdType="pmc">PMC7353311</ArticleId><ArticleId IdType="doi">10.3390/nu12061824</ArticleId><ArticleId IdType="pii">nu12061824</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Oskarsson B., Gendron T.F., Staff N.P. Amyotrophic lateral sclerosis: An update for 2018. Mayo Clin. Proc. 2018;93:1617&#x2013;1628. doi: 10.1016/j.mayocp.2018.04.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mayocp.2018.04.007</ArticleId><ArticleId IdType="pubmed">30401437</ArticleId></ArticleIdList></Reference><Reference><Citation>Kumar V., Kashav T., Hassan M.I. Amyotrophic Lateral Sclerosis: Current Therapeutic Perspectives. In: Singh S., Joshi N., editors. Pathology, Prevention and Therapeutics of Neurodegenerative Disease. Springer; Singapore: 2019. pp. 207&#x2013;224.</Citation></Reference><Reference><Citation>Diaz-Amarilla P., Olivera-Bravo S., Trias E., Cragnolini A., Martinez-Palma L., Cassina P., Beckman J., Barbeito L. Phenotypically aberrant astrocytes that promote motoneuron damage in a model of inherited amyotrophic lateral sclerosis. Proc. Natl. Acad. Sci. USA. 2011;108:18126&#x2013;18131. doi: 10.1073/pnas.1110689108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1110689108</ArticleId><ArticleId IdType="pmc">PMC3207668</ArticleId><ArticleId IdType="pubmed">22010221</ArticleId></ArticleIdList></Reference><Reference><Citation>Haidet-Phillips A.M., Hester M.E., Miranda C.J., Meyer K., Braun L., Frakes A., Song S., Likhite S., Murtha M.J., Foust K.D., et al. Astrocytes from familial and sporadic ALS patients are toxic to motor neurons. Nat. Biotechnol. 2011;29:824&#x2013;828. doi: 10.1038/nbt.1957.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nbt.1957</ArticleId><ArticleId IdType="pmc">PMC3170425</ArticleId><ArticleId IdType="pubmed">21832997</ArticleId></ArticleIdList></Reference><Reference><Citation>Ram&#xed;rez-Jarqu&#xed;n U.N., Rojas F., van Zundert B., Tapia R. Chronic infusion of SOD1 (G93A) astrocyte-secreted factors induces spinal motoneuron degeneration and neuromuscular dysfunction in healthy rats. J. Cell Physiol. 2017;232:2610&#x2013;2615. doi: 10.1002/jcp.25827.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jcp.25827</ArticleId><ArticleId IdType="pubmed">28128448</ArticleId></ArticleIdList></Reference><Reference><Citation>Tyzack G.E., Hall C.E., Sibley C.R., Cymes T., Forostyak S., Carlino G., Meyer I.F., Schiavo G., Zhang S.C., Gibbons G.M., et al. A neuroprotective astrocyte state is induced by neuronal signal EphB1 but fails in ALS models. Nat. Commun. 2017;8:1164. doi: 10.1038/s41467-017-01283-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-017-01283-z</ArticleId><ArticleId IdType="pmc">PMC5660125</ArticleId><ArticleId IdType="pubmed">29079839</ArticleId></ArticleIdList></Reference><Reference><Citation>Madill M., McDonagh K., Ma J., Vajda A., McLoughlin P., O&#x2019;Brien T., Hardiman O., Shen S. Amyotrophic lateral sclerosis patient iPSC-derived astrocytes impair autophagy via non-cell autonomous mechanisms. Mol. Brain. 2017;10:22. doi: 10.1186/s13041-017-0300-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13041-017-0300-4</ArticleId><ArticleId IdType="pmc">PMC5470320</ArticleId><ArticleId IdType="pubmed">28610619</ArticleId></ArticleIdList></Reference><Reference><Citation>Rudnick N.D., Griffey C.J., Guarnieri P., Gerbino V., Wang X., Piersaint J.A., Tapia J.C., Rich M.M., Maniatis T. Distinct roles for motor neuron autophagy early and late in the SOD1G93A mouse model of ALS. Proc. Natl. Acad. Sci. USA. 2017;114:E8294&#x2013;E8303. doi: 10.1073/pnas.1704294114.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1704294114</ArticleId><ArticleId IdType="pmc">PMC5625902</ArticleId><ArticleId IdType="pubmed">28904095</ArticleId></ArticleIdList></Reference><Reference><Citation>Tripathi P., Rodriguez-Muela N., Klim J.R., de Boer A.S., Agrawal S., Sandoe J., Lopes C.S., Ogliari K.S., Williams L.A., Shear M., et al. Reactive astrocytes promote ALS-like degeneration and intracellular protein aggregation in human motor neurons by disrupting autophagy through TGF-&#x3b2;1. Stem Cell Rep. 2017;9:667&#x2013;680. doi: 10.1016/j.stemcr.2017.06.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.stemcr.2017.06.008</ArticleId><ArticleId IdType="pmc">PMC5549875</ArticleId><ArticleId IdType="pubmed">28712846</ArticleId></ArticleIdList></Reference><Reference><Citation>Meissner F., Molawi K., Zychlinsky A. Mutant superoxide dismutase 1-induced IL-1 accelerates ALS pathogenesis. Proc. Natl. Acad. Sci. USA. 2010;107:13046&#x2013;13050. doi: 10.1073/pnas.1002396107.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1002396107</ArticleId><ArticleId IdType="pmc">PMC2919927</ArticleId><ArticleId IdType="pubmed">20616033</ArticleId></ArticleIdList></Reference><Reference><Citation>Liddelow S.A., Guttenplan K.A., Clarke L.E., Bennett F.C., Bohlen C.J., Schirmer L., Bennett M.L., M&#xfc;nch A.E., Chung W.S., Peterson T.C., et al. Neurotoxic reactive astrocytes are induced by activated microglia. Nature. 2017;541:481&#x2013;487. doi: 10.1038/nature21029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature21029</ArticleId><ArticleId IdType="pmc">PMC5404890</ArticleId><ArticleId IdType="pubmed">28099414</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiao Q., Zhao W., Beers D.R., Yen A.A., Xie W., Henkel J.S., Appel S.H. Mutant SOD1(G93A) microglia are more neurotoxic relative to wild-type microglia. J. Neurochem. 2007;102:2008&#x2013;2019. doi: 10.1111/j.1471-4159.2007.04677.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1471-4159.2007.04677.x</ArticleId><ArticleId IdType="pubmed">17555556</ArticleId></ArticleIdList></Reference><Reference><Citation>Graber D.J., Hickey W.F., Harris B.T. Progressive changes in microglia and macrophages in spinal cord and peripheral nerve in the transgenic rat model of amyotrophic lateral sclerosis. J. Neuroinflamm. 2010;7:8. doi: 10.1186/1742-2094-7-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1742-2094-7-8</ArticleId><ArticleId IdType="pmc">PMC2825214</ArticleId><ArticleId IdType="pubmed">20109233</ArticleId></ArticleIdList></Reference><Reference><Citation>Brettschneider J., Toledo J.B., Van Deerlin V.M., Elman L., McCluskey L., Lee V.M., Trojanowski J.Q. Microglial activation correlates with disease progression and upper motor neuron clinical symptoms in amyotrophic lateral sclerosis. PLoS ONE. 2012;7:e39216. doi: 10.1371/journal.pone.0039216.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0039216</ArticleId><ArticleId IdType="pmc">PMC3375234</ArticleId><ArticleId IdType="pubmed">22720079</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiu I.M., Morimoto E.T., Goodarzi H., Liao J.T., O&#x2019;Keeffe S., Phatnani H.P., Muratet M., Carroll M.C., Levy S., Tavazoie S., et al. A neurodegeneration-specific gene-expression signature of acutely isolated microglia from an amyotrophic lateral sclerosis mouse model. Cell Rep. 2013;4:385&#x2013;401. doi: 10.1016/j.celrep.2013.06.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2013.06.018</ArticleId><ArticleId IdType="pmc">PMC4272581</ArticleId><ArticleId IdType="pubmed">23850290</ArticleId></ArticleIdList></Reference><Reference><Citation>D&#x2019;Amico E., Factor-Litvak P., Santella R.M., Mitsumoto H. Clinical perspective on oxidative stress in sporadic amyotrophic lateral sclerosis. Free Radic. Biol. Med. 2013;65:509&#x2013;527. doi: 10.1016/j.freeradbiomed.2013.06.029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.freeradbiomed.2013.06.029</ArticleId><ArticleId IdType="pmc">PMC3859834</ArticleId><ArticleId IdType="pubmed">23797033</ArticleId></ArticleIdList></Reference><Reference><Citation>Ikawa M., Okazawa H., Tsujikawa T., Matsunaga A., Yamamura O., Mori T., Hamano T., Kiyono Y., Nakamoto Y., Yoneda M. Increased oxidative stress is related to disease severity in the ALS motor cortex. Neurology. 2015;84:2033&#x2013;2039. doi: 10.1212/WNL.0000000000001588.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/WNL.0000000000001588</ArticleId><ArticleId IdType="pubmed">25904686</ArticleId></ArticleIdList></Reference><Reference><Citation>Almer G., Vukosavic S., Romero N., Przedborski S. Inducible nitric oxide synthase up-regulation in a transgenic mouse model of familial amyotrophic lateral sclerosis. J. Neurochem. 1999;72:2415&#x2013;2425. doi: 10.1046/j.1471-4159.1999.0722415.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1471-4159.1999.0722415.x</ArticleId><ArticleId IdType="pubmed">10349851</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee J., Ryu H., Kowall N.W. Differential regulation of neuronal and inducible nitric oxide synthase (NOS) in the spinal cord of mutant SOD1 (G93A) ALS mice. Biochem. Biophys. Res. Commun. 2009;387:202&#x2013;206. doi: 10.1016/j.bbrc.2009.07.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2009.07.007</ArticleId><ArticleId IdType="pmc">PMC2742676</ArticleId><ArticleId IdType="pubmed">19580782</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitsumoto H., Santella R.M., Liu X., Bogdanov M., Zipprich J., Wu H.C., Mahata J., Kilty M., Bednarz K., Bell D., et al. Oxidative stress biomarkers in sporadic ALS. Amyotroph Lateral Scler. 2008;9:177&#x2013;183. doi: 10.1080/17482960801933942.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/17482960801933942</ArticleId><ArticleId IdType="pmc">PMC4332387</ArticleId><ArticleId IdType="pubmed">18574762</ArticleId></ArticleIdList></Reference><Reference><Citation>Blasco H., Garcon G., Patin F., Veyrat-Durebex C., Boyer J., Devos D., Vourc&#x2019;h P., Andres C.R., Corcia P. Panel of oxidative stress and inflammatory biomarkers in ALS: A pilot study. Can. J. Neurol. Sci. 2017;44:90&#x2013;95. doi: 10.1017/cjn.2016.284.</Citation><ArticleIdList><ArticleId IdType="doi">10.1017/cjn.2016.284</ArticleId><ArticleId IdType="pubmed">27774920</ArticleId></ArticleIdList></Reference><Reference><Citation>Palomo G.M., Manfredi G. Exploring new pathways of neurodegeneration in ALS: The role of mitochondria quality control. Brain Res. 2015;1607:36&#x2013;46. doi: 10.1016/j.brainres.2014.09.065.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2014.09.065</ArticleId><ArticleId IdType="pmc">PMC4385426</ArticleId><ArticleId IdType="pubmed">25301687</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopez-Gonzalez R., Lu Y., Gendron T.F., Karydas A., Tran H., Yang D., Petrucelli L., Miller B.L., Almeida S., Gao F.B. Poly(GR) in C9ORF72-related ALS/FTD compromises mitochondrial function and increases oxidative stress and DNA damage in iPSC-derived motor neurons. Neuron. 2016;92:383&#x2013;391. doi: 10.1016/j.neuron.2016.09.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2016.09.015</ArticleId><ArticleId IdType="pmc">PMC5111366</ArticleId><ArticleId IdType="pubmed">27720481</ArticleId></ArticleIdList></Reference><Reference><Citation>Pickles S., Semmler S., Broom H.R., Destroismaisons L., Legroux L., Arbour N., Meiering E., Cashman N.R., Vande Velde C. ALS-linked misfolded SOD1 species have divergent impacts on mitochondria. Acta Neuropathol. Commun. 2016;4:43. doi: 10.1186/s40478-016-0313-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-016-0313-8</ArticleId><ArticleId IdType="pmc">PMC4847257</ArticleId><ArticleId IdType="pubmed">27121871</ArticleId></ArticleIdList></Reference><Reference><Citation>Carr&#xec; M.T., D&#x2019;Ambrosi N., Cozzolino M. Pathways to mitochondrial dysfunction in ALS pathogenesis. Biochem. Biophys. Res. Commun. 2017;483:1187&#x2013;1193. doi: 10.1016/j.bbrc.2016.07.055.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2016.07.055</ArticleId><ArticleId IdType="pubmed">27416757</ArticleId></ArticleIdList></Reference><Reference><Citation>Walczak J., D&#x119;bska-Vielhaber G., Vielhaber S., Szyma&#x144;ski J., Charzy&#x144;ska A., Duszy&#x144;ski J., Szczepanowska J. Distinction of sporadic and familial forms of ALS based on mitochondrial characteristics. FASEB J. 2018;33:4388&#x2013;4403. doi: 10.1096/fj.201801843R.</Citation><ArticleIdList><ArticleId IdType="doi">10.1096/fj.201801843R</ArticleId><ArticleId IdType="pubmed">30550341</ArticleId></ArticleIdList></Reference><Reference><Citation>Abu-Hamad S., Kahn J., Leyton-Jaimes M.F., Rosenblatt J., Israelson A. Misfolded SOD1 accumulation and mitochondrial association contribute to the selective vulnerability of motor neurons in familial ALS: Correlation to human disease. ACS Chem. Neurosci. 2017;8:2225&#x2013;2234. doi: 10.1021/acschemneuro.7b00140.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acschemneuro.7b00140</ArticleId><ArticleId IdType="pubmed">28715630</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhandari R., Kuhad A., Kuhad A. Edaravone: A new hope for deadly amyotrophic lateral sclerosis. Drugs Today. 2018;54:349&#x2013;360. doi: 10.1358/dot.2018.54.6.2828189.</Citation><ArticleIdList><ArticleId IdType="doi">10.1358/dot.2018.54.6.2828189</ArticleId><ArticleId IdType="pubmed">29998226</ArticleId></ArticleIdList></Reference><Reference><Citation>Kelsey N., Hulick W., Winter A., Ross E., Linseman D.A. Neuroprotective effects of anthocyanins on apoptosis induced by mitochondrial oxidative stress. Nutr. Neurosci. 2011;14:249&#x2013;259. doi: 10.1179/1476830511Y.0000000020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1179/1476830511Y.0000000020</ArticleId><ArticleId IdType="pubmed">22053756</ArticleId></ArticleIdList></Reference><Reference><Citation>Murukan G., Murugan K. Anthocyanin content of teak and its potential therapeutic traits: Some observations. World J. Pharm. Res. 2018;7:977&#x2013;985.</Citation></Reference><Reference><Citation>Winter A.N., Ross E.K., Wilkins H.M., Stankiewicz T.R., Wallace T., Miller K., Linseman D.A. An anthocyanin-enriched extract from strawberries delays disease onset and extends survival in the hSOD1G93A mouse model of amyotrophic lateral sclerosis. Nutr. Neurosci. 2018;21:414&#x2013;426. doi: 10.1080/1028415X.2017.1297023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/1028415X.2017.1297023</ArticleId><ArticleId IdType="pubmed">28276271</ArticleId></ArticleIdList></Reference><Reference><Citation>Winter A.N., Ross E.K., Khatter S., Miller K., Linseman D.A. Chemical basis for the disparate neuroprotective effects of the anthocyanins, callistephin and kuromanin, against nitrosative stress. Free Radic. Biol. Med. 2017;103:23&#x2013;34. doi: 10.1016/j.freeradbiomed.2016.12.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.freeradbiomed.2016.12.012</ArticleId><ArticleId IdType="pubmed">27986528</ArticleId></ArticleIdList></Reference><Reference><Citation>Losada-Barreiro S., Bravo-D&#xed;az C. Free radicals and polyphenols: The redox chemistry of neurodegenerative diseases. Eur. J. Med. Chem. 2017;133:379&#x2013;402. doi: 10.1016/j.ejmech.2017.03.061.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejmech.2017.03.061</ArticleId><ArticleId IdType="pubmed">28415050</ArticleId></ArticleIdList></Reference><Reference><Citation>Winter A.N., Brenner M.C., Punessen N., Snodgrass M., Byars C., Arora Y., Linseman D.A. Comparison of the neuroprotective and anti-inflammatory effects of the anthocyanin metabolites, protocatechuic acid and 4-hydroxybenzoic acid. Oxid. Med. Cell Longev. 2017;2017:6297080. doi: 10.1155/2017/6297080.</Citation><ArticleIdList><ArticleId IdType="doi">10.1155/2017/6297080</ArticleId><ArticleId IdType="pmc">PMC5504963</ArticleId><ArticleId IdType="pubmed">28740571</ArticleId></ArticleIdList></Reference><Reference><Citation>Mancuso R., Oliv&#xe1;n S., Osta R., Navarro X. Evolution of gait abnormalities in SOD1(G93A) transgenic mice. Brain Res. 2011;1406:65&#x2013;73. doi: 10.1016/j.brainres.2011.06.033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2011.06.033</ArticleId><ArticleId IdType="pubmed">21733494</ArticleId></ArticleIdList></Reference><Reference><Citation>Weydt P., Hong S., Kliot M., M&#xf6;ller T. Assessing disease onset and progression in the SOD1 mouse model of ALS. NeuroReport. 2003;14:1051&#x2013;1054. doi: 10.1097/00001756-200305230-00029.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00001756-200305230-00029</ArticleId><ArticleId IdType="pubmed">12802201</ArticleId></ArticleIdList></Reference><Reference><Citation>Seo J.S., Baek I.S., Leem Y.H., Kim T.K., Cho Y., Lee S.M., Park Y.H., Han P.L. SK-PC-B70M alleviates neurologic symptoms in G93A-SOD1 amyotrophic lateral sclerosis mice. Brain Res. 2011;1368:299&#x2013;307. doi: 10.1016/j.brainres.2010.10.048.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2010.10.048</ArticleId><ArticleId IdType="pubmed">20971081</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y.M., Jiang B., Bao Y.M., An L.J. Protocatechuic acid inhibits apoptosis by mitochondrial dysfunction in rotenone-induced PC12 cells. Toxicol In Vitro. 2008;22:430&#x2013;437. doi: 10.1016/j.tiv.2007.10.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tiv.2007.10.012</ArticleId><ArticleId IdType="pubmed">18082360</ArticleId></ArticleIdList></Reference><Reference><Citation>Semaming Y., Sripetchwandee J., Sa-Nguanmoo P., Pintana H., Pannangpetch P., Chattipakorn N., Chattipakorn S.C. Protocatechuic acid protects brain mitochondrial function in streptozotocin-induced diabetic rats. Appl. Physiol. Nutr. Metab. 2015;40:1078&#x2013;1081. doi: 10.1139/apnm-2015-0158.</Citation><ArticleIdList><ArticleId IdType="doi">10.1139/apnm-2015-0158</ArticleId><ArticleId IdType="pubmed">26316260</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakamura Y., Torikai K., Ohigashi H.A. A catechol antioxidant protocatechuic acid potentiates inflammatory leukocyte-derived oxidative stress in mouse skin via a tyrosinase bioactivation pathway. Free Radic. Biol. Med. 2001;30:967&#x2013;978. doi: 10.1016/S0891-5849(01)00481-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0891-5849(01)00481-6</ArticleId><ArticleId IdType="pubmed">11316576</ArticleId></ArticleIdList></Reference><Reference><Citation>Lende A.B., Kshirsagar A.D., Deshpande A.D., Muley M.M., Patil R.R., Bafna P.A., Naik S.R. Anti-inflammatory and analgesic activity of protocatechuic acid in rats and mice. Inflammopharmacology. 2011;19:255&#x2013;263. doi: 10.1007/s10787-011-0086-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s10787-011-0086-4</ArticleId><ArticleId IdType="pubmed">21748471</ArticleId></ArticleIdList></Reference><Reference><Citation>McGeer P.L., McGeer E.G. Inflammatory processes in amyotrophic lateral sclerosis. Muscle Nerve. 2002;26:459&#x2013;470. doi: 10.1002/mus.10191.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mus.10191</ArticleId><ArticleId IdType="pubmed">12362410</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Giorgio F.P., Carrasco M.A., Siao M.C., Maniatis T., Eggan K. Non-cell autonomous effect of glia on motor neurons in an embryonic stem cell-based ALS model. Nat. Neurosci. 2007;10:608&#x2013;614. doi: 10.1038/nn1885.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn1885</ArticleId><ArticleId IdType="pmc">PMC3139463</ArticleId><ArticleId IdType="pubmed">17435754</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamanaka K., Boillee S., Roberts E.A., Garcia M.L., McAlonis-Downes M., Mikse O.R., Cleveland D.W., Goldstein L.S. Mutant SOD1 in cell types other than motor neurons and oligodendrocytes accelerates onset of disease in ALS mice. Proc. Natl. Acad. Sci. USA. 2008;105:7594&#x2013;7599. doi: 10.1073/pnas.0802556105.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0802556105</ArticleId><ArticleId IdType="pmc">PMC2396671</ArticleId><ArticleId IdType="pubmed">18492803</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao W., Beers D.R., Henkel J.S., Zhang W., Urushitani M., Julien J.P., Appel S.H. Extracellular mutant SOD1 induces microglial-mediated motoneuron injury. Glia. 2010;58:231&#x2013;243. doi: 10.1002/glia.20919.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/glia.20919</ArticleId><ArticleId IdType="pmc">PMC2784168</ArticleId><ArticleId IdType="pubmed">19672969</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagai M., Re D.B., Nagata T., Chalazonitis A., Jessell T.M., Wichterle H., Przedborski S. Astrocytes expressing ALS-linked mutated SOD1 release factors selectively toxic to motor neurons. Nat. Neurosci. 2007;10:615&#x2013;622. doi: 10.1038/nn1876.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn1876</ArticleId><ArticleId IdType="pmc">PMC3799799</ArticleId><ArticleId IdType="pubmed">17435755</ArticleId></ArticleIdList></Reference><Reference><Citation>Min S.W., Ryu S.N., Kim D.H. Anti-inflammatory effects of black rice, cyanidin-3-O-beta-D-glucoside, and its metabolites, cyanidin and protocatechuic acid. Int. Immunopharmacol. 2010;10:959&#x2013;966. doi: 10.1016/j.intimp.2010.05.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.intimp.2010.05.009</ArticleId><ArticleId IdType="pubmed">20669401</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsai S.J., Yin M.C. Anti-glycative and anti-inflammatory effects of protocatechuic acid in brain of mice treated by D-galactose. Food Chem. Toxicol. 2012;50:3198&#x2013;3205. doi: 10.1016/j.fct.2012.05.056.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.fct.2012.05.056</ArticleId><ArticleId IdType="pubmed">22687555</ArticleId></ArticleIdList></Reference><Reference><Citation>Narai H., Manabe Y., Nagai M., Nagano I., Ohta Y., Murakami T., Takehisa Y., Kamiya T., Abe K. Early detachment of neuromuscular junction proteins in ALS mice with SODG93A mutation. Neurol. Int. 2009;1:e16. doi: 10.4081/ni.2009.e16.</Citation><ArticleIdList><ArticleId IdType="doi">10.4081/ni.2009.e16</ArticleId><ArticleId IdType="pmc">PMC3093225</ArticleId><ArticleId IdType="pubmed">21577353</ArticleId></ArticleIdList></Reference><Reference><Citation>Song Y., Cui T., Xie N., Zhang X., Qian Z., Liu J. Protocatechuic acid improves cognitive deficits and attenuates amyloid deposits, inflammatory response in aged A&#x3b2;PP/PS1 double transgenic mice. Int. Immunopharmacol. 2014;20:276&#x2013;281. doi: 10.1016/j.intimp.2014.03.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.intimp.2014.03.006</ArticleId><ArticleId IdType="pubmed">24667368</ArticleId></ArticleIdList></Reference><Reference><Citation>Subash S., Essa M.M., Al-Asmi A., Al-Adawi S., Vaishnav R., Guillemin G.J. Effect of dietary supplementation of dates in Alzheimer&#x2019;s disease APPsw/2576 transgenic mice on oxidative stress and antioxidant status. Nutr. Neurosci. 2015;18:281&#x2013;288. doi: 10.1179/1476830514Y.0000000134.</Citation><ArticleIdList><ArticleId IdType="doi">10.1179/1476830514Y.0000000134</ArticleId><ArticleId IdType="pubmed">24954036</ArticleId></ArticleIdList></Reference><Reference><Citation>Subash S., Essa M.M., Braidy N., Awlad-Thani K., Vaishnav R., Al-Adawi S., Al-Asmi A., Guillemin G.J. Diet rich in date palm fruits improves memory, learning and reduces beta amyloid in transgenic mouse model of Alzheimer&#x2019;s disease. J. Ayurveda Integr. Med. 2015;6:111&#x2013;120.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4484046</ArticleId><ArticleId IdType="pubmed">26167001</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Z., Li G., Szeto S.S.W., Chong C.M., Quan Q., Huang C., Cui W., Guo B., Wang Y., Han Y., et al. Examining the neuroprotective effects of protocatechuic acid and chrysin on in vitro and in vivo models of Parkinson disease. Free Radic. Biol. Med. 2015;84:331&#x2013;343. doi: 10.1016/j.freeradbiomed.2015.02.030.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.freeradbiomed.2015.02.030</ArticleId><ArticleId IdType="pubmed">25769424</ArticleId></ArticleIdList></Reference><Reference><Citation>An L.J., Guan S., Shi G.F., Bao Y.M., Duan Y.L., Jiang B. Protocatechuic acid from Alpinia oxyphylla against MPP+-induced neurotoxicity in PC12 cells. Food Chem. Toxicol. 2006;44:436&#x2013;443. doi: 10.1016/j.fct.2005.08.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.fct.2005.08.017</ArticleId><ArticleId IdType="pubmed">16223555</ArticleId></ArticleIdList></Reference><Reference><Citation>Guan S., Jiang B., Bao Y.M., An L.J. Protocatechuic acid suppresses MPP+-induced mitochondrial dysfunction and apoptotic cell death in PC12 cells. Food Chem. Toxicol. 2006;44:1659&#x2013;1666. doi: 10.1016/j.fct.2006.05.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.fct.2006.05.004</ArticleId><ArticleId IdType="pubmed">16806628</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang H.N., An C.N., Zhang H.N., Pu X.P. Protocatechuic acid inhibits neurotoxicity induced by MPTP in vivo. Neurosci. Lett. 2010;474:99&#x2013;103. doi: 10.1016/j.neulet.2010.03.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neulet.2010.03.016</ArticleId><ArticleId IdType="pubmed">20227465</ArticleId></ArticleIdList></Reference><Reference><Citation>Hornedo-Ortega R., &#xc1;lvarez-Fern&#xe1;ndez M.A., Cerezo A.B., Richard T., Troncoso A.M., Garcia-Parrilla M.C. Protocatechuic acid: Inhibition of fibril formation, destabilization of preformed fibrils of amyloid-&#x3b2; and &#x3b1;-synuclein, and neuroprotection. J. Agric. Food Chem. 2016;64:7722&#x2013;7732. doi: 10.1021/acs.jafc.6b03217.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.jafc.6b03217</ArticleId><ArticleId IdType="pubmed">27686873</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>